424 related articles for article (PubMed ID: 19995843)
1. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
Montalban X; Sastre-Garriga J; Filippi M; Khaleeli Z; Téllez N; Vellinga MM; Tur C; Brochet B; Barkhof F; Rovaris M; Miller DH; Polman CH; Rovira A; Thompson AJ
Mult Scler; 2009 Dec; 15(12):1459-65. PubMed ID: 19995843
[TBL] [Abstract][Full Text] [Related]
2. A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.
Kelly SB; Kinsella K; Duggan M; Tubridy N; McGuigan C; Hutchinson M
Mult Scler; 2013 Jul; 19(8):1095-100. PubMed ID: 23132903
[TBL] [Abstract][Full Text] [Related]
3. Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.
Sola P; Mandrioli J; Simone AM; Ferraro D; Bedin R; Annecca R; Venneri MG; Nichelli PF; Merelli E
Mult Scler; 2011 Mar; 17(3):303-11. PubMed ID: 21078694
[TBL] [Abstract][Full Text] [Related]
4. Primary progressive multiple sclerosis: a comparative study of the diagnostic criteria.
de Seze J; Debouverie M; Waucquier N; Steinmetz G; Pittion S; Zephir H; Fleury M; Blanc F; Vermersch P
Mult Scler; 2007 Jun; 13(5):622-5. PubMed ID: 17548441
[TBL] [Abstract][Full Text] [Related]
5. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
[TBL] [Abstract][Full Text] [Related]
6. Clinical, MRI, CSF and electrophysiological findings in different stages of multiple sclerosis.
Rot U; Mesec A
Clin Neurol Neurosurg; 2006 Mar; 108(3):271-4. PubMed ID: 16378679
[TBL] [Abstract][Full Text] [Related]
7. [Primary progressive forms of multiple sclerosis: application of the new diagnostic criteria in French].
De Seze J; Mackowiak A; Stojkovic T; Ferriby D; Hautecoeur P; Vermersch P
Rev Neurol (Paris); 2002 Mar; 158(3):341-5. PubMed ID: 11976594
[TBL] [Abstract][Full Text] [Related]
8. Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.
Komori M; Matsuyama Y; Nirasawa T; Thiele H; Becker M; Alexandrov T; Saida T; Tanaka M; Matsuo H; Tomimoto H; Takahashi R; Tashiro K; Ikegawa M; Kondo T
Ann Neurol; 2012 May; 71(5):614-23. PubMed ID: 22522477
[TBL] [Abstract][Full Text] [Related]
9. Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis.
Verbeek MM; Notting EA; Faas B; Claessens-Linskens R; Jongen PJ
Acta Neurol Scand; 2010 May; 121(5):309-14. PubMed ID: 19925532
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of cerebrospinal fluid in multiple sclerosis.
Siritho S; Freedman MS
J Neurol Sci; 2009 Apr; 279(1-2):21-5. PubMed ID: 19181345
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.
Khademi M; Kockum I; Andersson ML; Iacobaeus E; Brundin L; Sellebjerg F; Hillert J; Piehl F; Olsson T
Mult Scler; 2011 Mar; 17(3):335-43. PubMed ID: 21135023
[TBL] [Abstract][Full Text] [Related]
12. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
[TBL] [Abstract][Full Text] [Related]
13. Clinical, magnetic resonance imaging, cerebrospinal fluid and electrophysiological characteristics of the earliest multiple sclerosis.
Rot U; Ledinek AH; Jazbec SS
Clin Neurol Neurosurg; 2008 Mar; 110(3):233-8. PubMed ID: 18093725
[TBL] [Abstract][Full Text] [Related]
14. Performance of the Swanton multiple sclerosis criteria for dissemination in space.
Nielsen JM; Uitdehaag BM; Korteweg T; Barkhof F; Polman CH
Mult Scler; 2010 Aug; 16(8):985-7. PubMed ID: 20547588
[TBL] [Abstract][Full Text] [Related]
15. Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.
Kragt JJ; Thompson AJ; Montalban X; Tintoré M; Río J; Polman CH; Uitdehaag BM
Neurology; 2008 Mar; 70(13 Pt 2):1084-91. PubMed ID: 18184917
[TBL] [Abstract][Full Text] [Related]
16. Lesion enhancement diminishes with time in primary progressive multiple sclerosis.
Khaleeli Z; Ciccarelli O; Mizskiel K; Altmann D; Miller DH; Thompson AJ
Mult Scler; 2010 Mar; 16(3):317-24. PubMed ID: 20203148
[TBL] [Abstract][Full Text] [Related]
17. CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.
Villar LM; Masterman T; Casanova B; Gómez-Rial J; Espiño M; Sádaba MC; González-Porqué P; Coret F; Alvarez-Cermeño JC
J Neuroimmunol; 2009 Jun; 211(1-2):101-4. PubMed ID: 19443047
[TBL] [Abstract][Full Text] [Related]
18. Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
Lourenco P; Shirani A; Saeedi J; Oger J; Schreiber WE; Tremlett H
Mult Scler; 2013 Apr; 19(5):577-84. PubMed ID: 22961214
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic criteria of multiple sclerosis with reference to different clinical forms].
Dimitri D
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):914-28. PubMed ID: 11787356
[TBL] [Abstract][Full Text] [Related]
20. The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis.
Zipoli V; Hakiki B; Portaccio E; Lolli F; Siracusa G; Giannini M; Pantoni L; Pescini F; Sorbi S; Amato MP
Mult Scler; 2009 Apr; 15(4):472-8. PubMed ID: 19153171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
